Kathleen A. Rickard, Chief Medical Officer at Verona Pharma plc (VRNA), sold 290,640 shares at $1.92 ($527K) on 2023-11-03, disclosed to the SEC on 2023-11-03.
Scheduled sale ($527k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.74 | 173,136 | $301K | 57.2% |
| 2 | $1.92 | 58,752 | $113K | 21.4% |
| 3 | $1.92 | 58,752 | $113K | 21.4% |
| Total | $1.81 avg | 290,640 | $527K | 100% |
| Filing → |
| VRNA | SELL | 2025-05-05 | $881K | — | Filing → |
| VRNA | SELL | 2025-05-01 | $618K | — | Filing → |
| VRNA | SELL | 2025-03-13 | $1.3M | — | Filing → |